-
1
-
-
0005673779
-
Microbiological assays
-
D. S. Reeves, R. Wise, J. M. Andrews, and L. O. White ed, Oxford University Press, Oxford, United Kingdom
-
Andrews, J. M. 1999. Microbiological assays, p. 35-44. In D. S. Reeves, R. Wise, J. M. Andrews, and L. O. White (ed.), Clinical antimicrobial assays. Oxford University Press, Oxford, United Kingdom.
-
(1999)
Clinical antimicrobial assays
, pp. 35-44
-
-
Andrews, J.M.1
-
2
-
-
0036151585
-
Antibiotic therapy of community respiratory tract infections: Strategies for optimal outcomes and minimized resistance emergence
-
Ball, P., F. Baquero, O. Cars, T. File, J. Garau, K. Klugman, D. E. Low, E. Rubinstein, R. Wise, et al. 2002. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49:31-40.
-
(2002)
J. Antimicrob. Chemother
, vol.49
, pp. 31-40
-
-
Ball, P.1
Baquero, F.2
Cars, O.3
File, T.4
Garau, J.5
Klugman, K.6
Low, D.E.7
Rubinstein, E.8
Wise, R.9
-
3
-
-
0021832112
-
In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives
-
Blaser, J. 1985. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. Antimicrob. Chemother. 15(Suppl. A):125-130.
-
(1985)
J. Antimicrob. Chemother
, vol.15
, Issue.SUPPL. A
, pp. 125-130
-
-
Blaser, J.1
-
4
-
-
34447104801
-
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in gram-positives
-
Cafini, F., L. Aguilar, N. Gonzalez, M. J. Gimenez, M. Torrico, L. Alou, D. Sevillano, P. Vallejo, and J. Prieto. 2007. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in gram-positives. J. Antimicrob. Chemother. 59:1185-1189.
-
(2007)
J. Antimicrob. Chemother
, vol.59
, pp. 1185-1189
-
-
Cafini, F.1
Aguilar, L.2
Gonzalez, N.3
Gimenez, M.J.4
Torrico, M.5
Alou, L.6
Sevillano, D.7
Vallejo, P.8
Prieto, J.9
-
5
-
-
33845918505
-
Performance standards for antimicrobial susceptibility testing
-
Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA
-
Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI/NCCLS document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
-
(2005)
fifteenth informational supplement. CLSI/NCCLS document
-
-
-
6
-
-
0031952586
-
Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
-
Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-10.
-
(1998)
Clin. Infect. Dis
, vol.26
, pp. 1-10
-
-
Craig, W.A.1
-
7
-
-
0016913384
-
Significance of serum protein and tissue binding of antimicrobial agents
-
Craig, W. A., and C. M. Kunin. 1976. Significance of serum protein and tissue binding of antimicrobial agents. Annu. Rev. Med. 27:287-300.
-
(1976)
Annu. Rev. Med
, vol.27
, pp. 287-300
-
-
Craig, W.A.1
Kunin, C.M.2
-
8
-
-
0035984795
-
Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae
-
Dabernat, H., C. Delmas, M. Seguy, R. Pelissier, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
-
(2002)
Antimicrob. Agents Chemother
, vol.46
, pp. 2208-2218
-
-
Dabernat, H.1
Delmas, C.2
Seguy, M.3
Pelissier, R.4
Faucon, G.5
Bennamani, S.6
Pasquier, C.7
-
9
-
-
0035136786
-
Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy
-
Dagan, R., K. P. Klugman, W. A. Craig, and F. Baquero. 2001. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J. Antimicrob. Chemother. 47:129-140.
-
(2001)
J. Antimicrob. Chemother
, vol.47
, pp. 129-140
-
-
Dagan, R.1
Klugman, K.P.2
Craig, W.A.3
Baquero, F.4
-
10
-
-
34547849666
-
Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media
-
Fenoll, A., L. Aguilar, O. Robledo, M. J. Gimenez, D. Tarrago, J. J. Granizo, M. Gimeno, and P. Coronel. 2007. Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J. Antimicrob. Chemother. 60:323-327.
-
(2007)
J. Antimicrob. Chemother
, vol.60
, pp. 323-327
-
-
Fenoll, A.1
Aguilar, L.2
Robledo, O.3
Gimenez, M.J.4
Tarrago, D.5
Granizo, J.J.6
Gimeno, M.7
Coronel, P.8
-
11
-
-
34447256788
-
Ampicillin-resistant non-β-lactamase producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and Cefixime
-
Garcia-Cobos, S., J. Campos, E. Lázare, F. Román, E. Cercenado, C. García-Rey, M. Pérez-Vázquex, J. Oteo, and F. de Abajo. 2007. Ampicillin-resistant non-β-lactamase producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and Cefixime. Antimicrob. Agents Chemother. 51:2564-2573.
-
(2007)
Antimicrob. Agents Chemother
, vol.51
, pp. 2564-2573
-
-
Garcia-Cobos, S.1
Campos, J.2
Lázare, E.3
Román, F.4
Cercenado, E.5
García-Rey, C.6
Pérez-Vázquex, M.7
Oteo, J.8
de Abajo, F.9
-
12
-
-
34347248739
-
Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins
-
Garcia-de-Lomas, J., M. Lerma, L. Cebrian, J. L. Juan-Banon, P. Coronel, M. J. Gimenez, and L. Aguilar. 2007. Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins. Int. J. Antimicrob. Agents 30:190-192.
-
(2007)
Int. J. Antimicrob. Agents
, vol.30
, pp. 190-192
-
-
Garcia-de-Lomas, J.1
Lerma, M.2
Cebrian, L.3
Juan-Banon, J.L.4
Coronel, P.5
Gimenez, M.J.6
Aguilar, L.7
-
13
-
-
0033288551
-
Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain: The results of a 1-year (1996-97) multicenter surveillance study
-
Garcia-Rodriguez, J. A., F. Baquero, J. Garcia de Lomas, L. Aguilar, et al. 1999. Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain: the results of a 1-year (1996-97) multicenter surveillance study. Infection 27:265-267.
-
(1999)
Infection
, vol.27
, pp. 265-267
-
-
Garcia-Rodriguez, J.A.1
Baquero, F.2
Garcia de Lomas, J.3
Aguilar, L.4
-
14
-
-
0027931788
-
Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: A prospective study in Murcia, Spain, 1983-1992
-
Gómez, J., J. Ruiz-Gómez, J. L. Hernández- Cardona, M. L. Nuñez, M. Canteras, and M. Valdés. 1994. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992. Chemotherapy 40:299-303.
-
(1994)
Chemotherapy
, vol.40
, pp. 299-303
-
-
Gómez, J.1
Ruiz-Gómez, J.2
Hernández- Cardona, J.L.3
Nuñez, M.L.4
Canteras, M.5
Valdés, M.6
-
15
-
-
2142767352
-
Rapidly increasing prevalence of beta-lactamase-nonproduring, ampiculin-resistant Haemophilus influenzae type b in patients with meningitis
-
Hasegawa, K., N. Chiba, R. Kobayashi, S. Y. Murayama, S. Iwata, K. Sunakawa, and K. Ubukata. 2004. Rapidly increasing prevalence of beta-lactamase-nonproduring, ampiculin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 48:1509-1514.
-
(2004)
Antimicrob. Agents Chemother
, vol.48
, pp. 1509-1514
-
-
Hasegawa, K.1
Chiba, N.2
Kobayashi, R.3
Murayama, S.Y.4
Iwata, S.5
Sunakawa, K.6
Ubukata, K.7
-
16
-
-
0037357099
-
Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States
-
Hasegawa, K., K. Yamamoto, N. Chiba, R. Kobayashi, K. Nagai, M. R. Jacobs, P. C. Appelbaum, K. Sunakawa, and K. Ubukata. 2003. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist. 9:39-46.
-
(2003)
Microb. Drug Resist
, vol.9
, pp. 39-46
-
-
Hasegawa, K.1
Yamamoto, K.2
Chiba, N.3
Kobayashi, R.4
Nagai, K.5
Jacobs, M.R.6
Appelbaum, P.C.7
Sunakawa, K.8
Ubukata, K.9
-
17
-
-
0032854834
-
Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study
-
Jacobs, M. R., S. Bajaksouzian, A. Zilles, G. Lin, G. A. Pankuch, and P. C. Appelbaum. 1999. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob. Agents Chemother. 43:1901-1908.
-
(1999)
Antimicrob. Agents Chemother
, vol.43
, pp. 1901-1908
-
-
Jacobs, M.R.1
Bajaksouzian, S.2
Zilles, A.3
Lin, G.4
Pankuch, G.A.5
Appelbaum, P.C.6
-
18
-
-
33748687374
-
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae
-
Jansen, W. T., A. Verel, M. Beitsma, J. Verhoef, and D. Milatovic. 2006. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58:873-877.
-
(2006)
J. Antimicrob. Chemother
, vol.58
, pp. 873-877
-
-
Jansen, W.T.1
Verel, A.2
Beitsma, M.3
Verhoef, J.4
Milatovic, D.5
-
19
-
-
0035005015
-
The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate
-
Kaye, C. M., A. Allen, S. Perry, M. McDonagh, M. Davy, K. Storm, N. Bird, and O. Dewit. 2001. The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate. Clin. Ther. 23:578-584.
-
(2001)
Clin. Ther
, vol.23
, pp. 578-584
-
-
Kaye, C.M.1
Allen, A.2
Perry, S.3
McDonagh, M.4
Davy, M.5
Storm, K.6
Bird, N.7
Dewit, O.8
-
20
-
-
0021837433
-
Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae
-
Lavoie, G. Y., and M. G. Bergeron. 1985. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae. Antimicrob. Agents Chemother;. 28:404-412.
-
(1985)
Antimicrob. Agents Chemother
, vol.28
, pp. 404-412
-
-
Lavoie, G.Y.1
Bergeron, M.G.2
-
21
-
-
0036805581
-
Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: A comparison of different dosage regimens including a pharmacokinetically enhanced formulation
-
Lowdin, E., O. Cars, and I. Odenholt. 2002. Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation. Clin. Microbiol. Infect;. 8:646-653.
-
(2002)
Clin. Microbiol. Infect
, vol.8
, pp. 646-653
-
-
Lowdin, E.1
Cars, O.2
Odenholt, I.3
-
22
-
-
33745586714
-
Principles of anti-infective therapy
-
G. L. Mandell, J. E. Bennett, and R. Dolin ed, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA
-
Moellering, R. C., and G. M. Eliopoulos. 2005. Principles of anti-infective therapy, p. 242-253. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett principles and practice of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA.
-
(2005)
Mandell, Douglas, and Bennett principles and practice of infectious diseases
, pp. 242-253
-
-
Moellering, R.C.1
Eliopoulos, G.M.2
-
23
-
-
0034769863
-
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999
-
Marco, F., J. Garcia-de-Lomas, C. Garcia-Rey, E. Bouza, L. Aguilar, C. Fernandez-Mazarrasa, et al. 2001. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob. Agents Chemother. 45:3226-3228.
-
(2001)
Antimicrob. Agents Chemother
, vol.45
, pp. 3226-3228
-
-
Marco, F.1
Garcia-de-Lomas, J.2
Garcia-Rey, C.3
Bouza, E.4
Aguilar, L.5
Fernandez-Mazarrasa, C.6
-
24
-
-
0031049862
-
In-vitro pharmacodynamic simulation of clavulanic acid concentrations: Effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity
-
Martin, M., L. Aguilar, I. P. Balcabao, M. L. Gomez-Lus, R. Dal-Re, and J. Prieto. 1997. In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity. J. Antimicrob. Chemother. 39:290-292.
-
(1997)
J. Antimicrob. Chemother
, vol.39
, pp. 290-292
-
-
Martin, M.1
Aguilar, L.2
Balcabao, I.P.3
Gomez-Lus, M.L.4
Dal-Re, R.5
Prieto, J.6
-
25
-
-
0347519283
-
Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanic acid resistance in beta-lactamase- positive, amoxicillin/clavulanic acid-resistant Haemophilus influenzae
-
Matic, V., B. Bozdogan, M. R. Jacobs, K. Ubukata, and P. C. Appelbaum. 2003. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanic acid resistance in beta-lactamase- positive, amoxicillin/clavulanic acid-resistant Haemophilus influenzae. J. Antimicrob. Chemother. 52:1018-1021.
-
(2003)
J. Antimicrob. Chemother
, vol.52
, pp. 1018-1021
-
-
Matic, V.1
Bozdogan, B.2
Jacobs, M.R.3
Ubukata, K.4
Appelbaum, P.C.5
-
26
-
-
34948850637
-
-
Mulford, D., M. Mayer, and G. Witt. 2000. Effect of age and gender on the pharmacokinetics of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 310. American Society for Microbiology, Washington, DC.
-
Mulford, D., M. Mayer, and G. Witt. 2000. Effect of age and gender on the pharmacokinetics of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 310. American Society for Microbiology, Washington, DC.
-
-
-
-
27
-
-
34948877378
-
-
Mulford, D., M. Mayer, and G. Witt. 2000. Effect of renal impairment on the pharmacokinetic of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 311. American Society for Microbiology, Washington, DC.
-
Mulford, D., M. Mayer, and G. Witt. 2000. Effect of renal impairment on the pharmacokinetic of cefditoren. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. 2000, abstr. 311. American Society for Microbiology, Washington, DC.
-
-
-
-
28
-
-
34948877875
-
-
National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically; approved standard, 6th ed. NCCLS M7-A6. NCCLS, Wayne, PA.
-
National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically; approved standard, 6th ed. NCCLS M7-A6. NCCLS, Wayne, PA.
-
-
-
-
29
-
-
20944431706
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
-
Perez-Trallero, E., C. Garcia-de-la-Fuente, C. Garcia-Rey, F. Baquero, L. Aguilar, R. Dal-Re, J. Garcia-de-Lomas, et al. 2005. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob. Agents Chemother. 49:1965-1972.
-
(2005)
Antimicrob. Agents Chemother
, vol.49
, pp. 1965-1972
-
-
Perez-Trallero, E.1
Garcia-de-la-Fuente, C.2
Garcia-Rey, C.3
Baquero, F.4
Aguilar, L.5
Dal-Re, R.6
Garcia-de-Lomas, J.7
-
30
-
-
0031807596
-
In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: A controlled study with vancomycin
-
Prieto, J., L. Aguilar, M. J. Gimenez, D. Toro, M. L. Gomez-Lus, R. Dal-Re, and I. P. Balcabao. 1998. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: a controlled study with vancomycin. Antimicrob. Agents Chemother. 42:1574-1577.
-
(1998)
Antimicrob. Agents Chemother
, vol.42
, pp. 1574-1577
-
-
Prieto, J.1
Aguilar, L.2
Gimenez, M.J.3
Toro, D.4
Gomez-Lus, M.L.5
Dal-Re, R.6
Balcabao, I.P.7
-
31
-
-
0028301107
-
Determination of susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases
-
Scriver, S. R., S. L. Walmsley, C. L. Kau, D. J. Hoban, J. Brunton, A. McGeer, T. C. Moore, and E. Witwicki. 1994. Determination of susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrob. Agents Chemother. 38:1678-1680.
-
(1994)
Antimicrob. Agents Chemother
, vol.38
, pp. 1678-1680
-
-
Scriver, S.R.1
Walmsley, S.L.2
Kau, C.L.3
Hoban, D.J.4
Brunton, J.5
McGeer, A.6
Moore, T.C.7
Witwicki, E.8
-
32
-
-
0032927975
-
Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan
-
Seki, H., Y. Kasahara, K. Ohta, Y. Saikawa, R. Sumita, A. Yachie, S. Fujita, and S. Koizumi. 1999. Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy 45:15-21.
-
(1999)
Chemotherapy
, vol.45
, pp. 15-21
-
-
Seki, H.1
Kasahara, Y.2
Ohta, K.3
Saikawa, Y.4
Sumita, R.5
Yachie, A.6
Fujita, S.7
Koizumi, S.8
-
33
-
-
12344323596
-
Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation
-
Sevillano, D., A. Calvo, M. J. Gimenez, L. Alou, L. Aguilar, E. Valero, A. Carcas, and J. Prieto. 2004. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation. J. Antimicrob. Chemother. 54:1148-1151.
-
(2004)
J. Antimicrob. Chemother
, vol.54
, pp. 1148-1151
-
-
Sevillano, D.1
Calvo, A.2
Gimenez, M.J.3
Alou, L.4
Aguilar, L.5
Valero, E.6
Carcas, A.7
Prieto, J.8
-
34
-
-
34447576587
-
Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin resistant Streptococcus pneumoniae
-
in press
-
Sevillano, D., M. J. Gimenez, L. Alou, L. Aguilar, F. Cafini, M. Torrico, N. González, O. Echeverria, P. Coronel, and J. Prieto. Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin resistant Streptococcus pneumoniae. J. Antimicrob. Chemother., in press.
-
J. Antimicrob. Chemother
-
-
Sevillano, D.1
Gimenez, M.J.2
Alou, L.3
Aguilar, L.4
Cafini, F.5
Torrico, M.6
González, N.7
Echeverria, O.8
Coronel, P.9
Prieto, J.10
-
35
-
-
0034997881
-
Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae
-
Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
-
(2001)
Antimicrob. Agents Chemother
, vol.45
, pp. 1693-1699
-
-
Ubukata, K.1
Shibasaki, Y.2
Yamamoto, K.3
Chiba, N.4
Hasegawa, K.5
Takeuchi, Y.6
Sunakawa, K.7
Inoue, M.8
Konno, M.9
-
36
-
-
9944248106
-
Cefditoren pivoxil: A review of its use in the treatment of bacterial infections
-
Wellington, K., and M. P. Curran. 2004. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections. Drugs 64:2597-2618.
-
(2004)
Drugs
, vol.64
, pp. 2597-2618
-
-
Wellington, K.1
Curran, M.P.2
|